Pharmaceutical
September 10, 2008
Biotechnology company ImClone Systems Inc., reported that it has received an offer from a large pharmaceuticals company to buy the company for $70 a share in cash, according to Reuters.
Read More
September 5, 2008
A Wake County judge has awarded more than $57 million to a Durham drug development company after finding that a former Serenex employee, chemist Yunsheng Huang, stole experimental cancer formulas
Read More
August 29, 2008
Pfizer Inc. said Friday a court in Denmark has blocked Ranbaxy Laboratories from launching a generic version of the blockbuster cholesterol drug Lipitor in that country. Pfizer said a court
Read More
August 18, 2008
The Associated Press reports that layoffs and restructurings are taking a toll on drug and medical technology companies in New Jersey, one of the state''s most important industries. A survey
Read More
August 13, 2008
The Associated Press reports that drugmaker Merck & Co. Inc. spent nearly $1.2 million lobbying on pharmaceutical issues in the second quarter, according to a recent disclosure form. Merck lobbied
Read More
August 11, 2008
The Associated Press reports that Pfizer Inc. will relocate its biotech research center to San Francisco. The company plans to move the unit in early 2010 from its current location
Read More
August 4, 2008
When Abbott Laboratories Inc. hiked up the price of a popular AIDS drug by 400 percent in 2003, executives prepared for the inevitable public relations hit, according to the Associated
Read More
July 28, 2008
Sanofi-Aventis SA said its planned 276 million pound ($551 million) acquisition of Acambis PLC will bolster its leading position in the vaccine market and strengthen its development pipeline, according to
Read More
July 28, 2008
New bubble trap is specifically designed for sanitary service. The trap is the first of its kind in that it is designed to be crevice-free and self-draining, efficiently removing unwanted
Read More
July 16, 2008
According to the Associated Press, several states expect multimillion-dollar payouts from drug developer Bristol-Myers Squibb Co. as part of a settlement of allegations of Medicaid fraud and illegal drug marketing
Read More